<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Microbiology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">World antimicrobial resistance (AMR) awareness week</title>
    <FirstPage>5167</FirstPage>
    <LastPage>5167</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mohammad Mehdi</FirstName>
        <LastName>Feizabadi</LastName>
        <affiliation locale="en_US">Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">On the occasion of World Antimicrobial Resistance (AMR) Awareness Week, November 2024, we witnessed a lot of events throughout our country, Iran. Many different specialists throughout the country debated on the current situation, however, no one can predict the future outlook of this ongoing issue. The health policy makers try to find the right solutions for combating the drug-resistant superbugs but they should not ignore Microbiology principles. Carbapenem-resistant Klbesiella pneumoniae infections are definitely the main causes of morbidity and mortality in the Iranian Hospitals. In the current issue of this Journal, Dr. Solgi and his colleagues have raised an important and critical point: New Delhi metallo-beta-lactamase (NDM-MBL). Unfortunately, the number of cases infected with ceftazidime/avibactam-resistant Gram-negative bacteria has increased due to NDM-MBL production (Nearly 87% of K. pneumoniae clinical isolates in Isfahan). Therefore, our country resources are wasted with the current official protocol for administration of ceftazidime/avibactam, despite knowing that NDM-MBL producers are dominant. Physicians should be aware of the current situation of MBL strains in Iran, which is attainable through reviewing works published by Microbiologists in different provinces of Iran.
&#xD;

&#xA0;</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/5167</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/5167/1720</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Experimental prescription, rising resistance: the alarming misuse of ceftazidime-avibactam in healthcare systems</title>
    <FirstPage>720</FirstPage>
    <LastPage>721</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mojtaba</FirstName>
        <LastName>Akbari</LastName>
        <affiliation locale="en_US">Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Christian</FirstName>
        <LastName>Giske</LastName>
        <affiliation locale="en_US">Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden</affiliation>
      </Author>
      <Author>
        <FirstName>Hamid</FirstName>
        <LastName>Solgi</LastName>
        <affiliation locale="en_US">Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Amin Hospital, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">No Abstract No Abstract No Abstract</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/5161</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/5161/1721</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Systematic review and meta-analysis of colistin plus meropenem therapy for the treatment of nosocomial pneumonia</title>
    <FirstPage>722</FirstPage>
    <LastPage>731</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hazhir</FirstName>
        <LastName>Moradi</LastName>
        <affiliation locale="en_US">Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra Sadat</FirstName>
        <LastName>Sajadi-Javan</LastName>
        <affiliation locale="en_US">Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sarah</FirstName>
        <LastName>Mousavi</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Soodabeh</FirstName>
        <LastName>Rostami</LastName>
        <affiliation locale="en_US">Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Bita</FirstName>
        <LastName>Moradi Khaniabadi</LastName>
        <affiliation locale="en_US">Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>03</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>08</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Nosocomial pneumonia caused by multidrug-resistant gram-negative bacteria presents a significant challenge for healthcare systems, as there are limited effective treatments available. This systematic review and meta-analysis aim to investigate the outcomes of colistin plus meropenem combination therapy on nosocomial pneumonia.
Materials and Methods: An exhaustive search of PubMed, Scopus, Web of Science (WOS), and Embase databases was conducted, resulting in the extraction of 5 studies for qualitative assessment and meta-analysis. The study sample included 991 patients admitted with nosocomial pneumonia. The outcomes evaluated were clinical improvement, microbiological response, mortality, Sequential Organ Failure Assessment (SOFA) score, Acute Physiology and Chronic Health Evaluation (APACHE II) score, Charlson Comorbidity Index (CCI), Clinical Pulmonary Infection Score (CPIS), C-reactive protein (CRP) levels, procalcitonin (PCT) levels, and intensive care unit (ICU) duration.
Results: The results demonstrated that colistin plus meropenem combination therapy significantly improved clinical outcomes (OR = 1.37, 95% CI = 1.04-1.81, p = 0.027), reduced SOFA scores (OR = -0.28, 95% CI = -0.44 to -0.11, p = 0.001), and increased CCI scores (OR = 0.16, 95% CI = 0.02-0.29, p = 0.021) compared to other medications. However, other evaluated parameters did not show significant differences.
Conclusion: This meta-analysis indicates that colistin-meropenem combination therapy is superior to other colistin-based treatments for nosocomial pneumonia in terms of clinical improvement, SOFA score reduction, and CCI score increase. Nevertheless, other variables assessed did not exhibit remarkable differences between the treatment regimens.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4673</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4673/1722</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluating the in vitro activity of cefoperazone-sulbactam against Gram negative pathogens in blood stream infections using automated systems</title>
    <FirstPage>732</FirstPage>
    <LastPage>736</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Uksim</FirstName>
        <LastName>Qadri</LastName>
        <affiliation locale="en_US">Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Jammu and Kashmir, India</affiliation>
      </Author>
      <Author>
        <FirstName>Sofiya</FirstName>
        <LastName>Zaffar</LastName>
        <affiliation locale="en_US">Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Jammu and Kashmir, India</affiliation>
      </Author>
      <Author>
        <FirstName>Saleem</FirstName>
        <LastName>Wani</LastName>
        <affiliation locale="en_US">Department of General Medicine, Sher-i-Kashmir Institute of Medical Sciences, Jammu and Kashmir, India</affiliation>
      </Author>
      <Author>
        <FirstName>Shugufta</FirstName>
        <LastName>Roohi</LastName>
        <affiliation locale="en_US">Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Jammu and Kashmir, India</affiliation>
      </Author>
      <Author>
        <FirstName>Munazah</FirstName>
        <LastName>Aman</LastName>
        <affiliation locale="en_US">Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Jammu and Kashmir, India</affiliation>
      </Author>
      <Author>
        <FirstName>Sabah</FirstName>
        <LastName>Bhat</LastName>
        <affiliation locale="en_US">Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Jammu and Kashmir, India</affiliation>
      </Author>
      <Author>
        <FirstName>Umaya</FirstName>
        <LastName>Majid</LastName>
        <affiliation locale="en_US">Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Jammu and Kashmir, India</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>07</Month>
        <Day>05</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: The incidence of multidrug-resistant, Gram-negative organisms, isolated as the etiological agents of infections is ascending. The advent of novel antibiotics poses significant challenges, necessitating the optimization and utilization of extant antimicrobial agents. Cefoperazone, a third-generation cephalosporin and &#x3B2;-lactam antimicrobial, when combined with sulbactam, an irreversible &#x3B2;-lactamase inhibitor, mitigates the vulnerability of cefoperazone to &#x3B2;-lactamase-producing organisms. Nonetheless, regional data on the susceptibility patterns for this pharmacological combination remains scarce. The primary objective of this investigation was to assess the efficacy of the cefoperazone-sulbactam combination against prevalent Gram-negative bacteria isolated from blood cultures.
Materials and Methods: A total of 700 Gram-negative isolates, comprising Escherichia coli, Klebsiella pneumoniae, Acinetobacter species, and Pseudomonas aeruginosa, were procured using the BacT/Alert 3D system. The identification and susceptibility testing for cefoperazone-sulbactam were performed using the VITEK Compact ID and AST system. Comparative analysis was conducted against other tested antibiotics.
Results: The study revealed that cefoperazone-sulbactam exhibited commendable in-vitro activity against Gram-negative pathogens isolated from blood, surpassed only by colistin and tigecycline.
Conclusion: Cefoperazone-sulbactam demonstrates robust activity against the most frequently encountered clinical pathogens, suggesting its potential as an efficacious therapeutic agent. The findings underscore the imperative for ongoing surveillance of resistance patterns and trends among commonly used antimicrobials.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4891</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4891/1723</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Lessons from an 11-year retrospective cohort study of Escherichi coli causing UTI in Imam Hospital Ardabil, Iran</title>
    <FirstPage>737</FirstPage>
    <LastPage>744</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Pegah</FirstName>
        <LastName>Shakib</LastName>
        <affiliation locale="en_US">Razi Herbal Medicines Research Center, Department of Microbiology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Arzanlou</LastName>
        <affiliation locale="en_US">Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Pouria</FirstName>
        <LastName>Sobhi</LastName>
        <affiliation locale="en_US">Student Research Committee, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Mojebi</LastName>
        <affiliation locale="en_US">Student Research Committee, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Bahrami</LastName>
        <affiliation locale="en_US">Student Research Committee, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Faraz</FirstName>
        <LastName>Mahdizadeh</LastName>
        <affiliation locale="en_US">Student Research Committee, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Leyla</FirstName>
        <LastName>Asadi</LastName>
        <affiliation locale="en_US">Imam Hospital Laboratory, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Amanzadeh</LastName>
        <affiliation locale="en_US">Department of Health Information Management, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Mohammadnia</LastName>
        <affiliation locale="en_US">Department of Health Information Management, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farzad</FirstName>
        <LastName>Khademi</LastName>
        <affiliation locale="en_US">Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Rashid</FirstName>
        <LastName>Ramazanzadeh</LastName>
        <affiliation locale="en_US">Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>08</Month>
        <Day>03</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>15</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: The global problem of urinary tract infections (UTIs) caused by antibiotic-resistant bacteria is due to limited treatment options. This study aimed to examine the prevalence, etiology, and management implications of Escherichi coli causing UTI at Imam Hospital Ardabil, Iran.
Materials and Methods: 2340 samples of retrospective data on E. coli causing UTIs were collected at Imam Hospital in Ardabil, Iran, spanning from 2012 to 2022. The samples were cultured and isolated, and their antibiotic susceptibility was determined using standard laboratory methods and data were then organized and systematically categorized using Python.
Results: It was found that the lowest level of resistance was related to nitrofurantoin, followed by imipenem. In 2018, the number of E. coli patients resistant to trimethoprim was the highest. Cephalexin and ciprofloxacin trends indicate the reduction of the line during this retrospective period. There was a significant correlation between wards and some antibiotics like Cefepime, Cefotaxime, Ceftazidime, and Trimethoprim (P-Value &lt;0.05).
Conclusion: Significant correlations were identified between specific hospital wards and resistance to antibiotics. These findings underscore the need for continuous surveillance and tailored antibiotic stewardship programs to combat the rising trend of antibiotic resistance.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4964</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4964/1724</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">High prevalence of antimicrobial resistance genes in multidrug-resistant-ESBLs-producing Klebsiella pneumoniae post-COVID-19 pandemic</title>
    <FirstPage>745</FirstPage>
    <LastPage>754</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Golnar</FirstName>
        <LastName>Rahimzadeh</LastName>
        <affiliation locale="en_US">Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Shaghayegh</FirstName>
        <LastName>Rezai</LastName>
        <affiliation locale="en_US">Department of Medical Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ghazal</FirstName>
        <LastName>Abbasi</LastName>
        <affiliation locale="en_US">Students Research Committee, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Saman</FirstName>
        <LastName>Soleimanpour</LastName>
        <affiliation locale="en_US">Department of Medical Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Valadan</LastName>
        <affiliation locale="en_US">Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Laleh</FirstName>
        <LastName>Vahedi</LastName>
        <affiliation locale="en_US">Department of Pathology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Somayeh</FirstName>
        <LastName>Sheidaei</LastName>
        <affiliation locale="en_US">Department of Pathology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Faezeh Sadat</FirstName>
        <LastName>Movahedi</LastName>
        <affiliation locale="en_US">Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Raha</FirstName>
        <LastName>Rezai</LastName>
        <affiliation locale="en_US">Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Sadegh</FirstName>
        <LastName>Rezai</LastName>
        <affiliation locale="en_US">Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>07</Month>
        <Day>06</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>10</Month>
        <Day>31</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Klebsiella pneumoniae is a common pathogen associated with healthcare-related infections. It is particularly notable for its ability to develop resistance to multiple antibiotics, making treatment challenging. During the COVID-19 pandemic, increased antibiotic use to manage critically ill patients was contributed to the rise of multidrug-resistant Klebsiella pneumoniae. This study evaluated the antibiotic resistance patterns of multidrug-resistant, ESBL-producing Klebsiella pneumoniae in northern Iran after the COVID-19 pandemic.
Materials and Methods: This cross-sectional study was conducted between September 2022 and October 2023. Clinical samples were collected from patients with nosocomial infections at hospitals in Sari. This study included 114 multidrug-resistant ESBLs-producing Klebsiella pneumoniae isolates. Antimicrobial susceptibility was assessed using broth macro-dilution, and resistance genes were detected by multiplex PCR.
Results: Gentamicin, ampicillin-sulbactam, co-amoxiclav, and ceftazidime displayed the lowest activity against multidrug-resistant Klebsiella pneumoniae. In contrast, piperacillin-tazobactam showed the highest activity. The prevalence of resistance genes was as follows: blaTEM (99.12%), blaSHV (74.56%), blaCTX (88.60%), blaIMP (64.04%), acrA -B (92.98%), and OqXA -B (67.54%).
Conclusion: This study identified over 50% of antibiotic-resistance genes. Over half of multidrug-resistant Klebsiella pneumoniae isolates showed resistance to antibiotics except piperacillin-tazobactam, which is recommended for treating multidrug-resistant Klebsiella pneumoniae infections.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4892</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4892/1725</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Frequency and antibiotic resistance pattern of Salmonella spp. isolated from traditional dairies and raw milks collected in Yazd province, Iran</title>
    <FirstPage>755</FirstPage>
    <LastPage>762</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Raziyeh</FirstName>
        <LastName>Barzegar-Bafrouei</LastName>
        <affiliation locale="en_US">Department of Food Hygiene and Safety, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Bahador</FirstName>
        <LastName>Hajimohammadi</LastName>
        <affiliation locale="en_US">Department of Nutrition, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hengameh</FirstName>
        <LastName>Zandi</LastName>
        <affiliation locale="en_US">Department of Microbiology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Gilda</FirstName>
        <LastName>Eslami</LastName>
        <affiliation locale="en_US">Department of Medical Parasitology and Mycology, Isfahan Medical School, Isfahan University of Medical Sciences, Isfahan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Fallahzadeh</LastName>
        <affiliation locale="en_US">Departments of Biostatistics and Epidemiology, Research Center for Healthcare Data Modeling, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>04</Month>
        <Day>08</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>06</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Salmonellosis is among the most common food-born infections, caused by Salmonella spp. bacteria. Present study has investigated the frequency and antibiotic resistance pattern of Salmonella spp. isolated from traditional dairy products and raw milk supplied in Yazd, Iran.
Materials and Methods: In a cross-sectional study, 350 samples of raw milk and traditional dairy products were randomly collected from July to September 2018. Following culturing the samples, isolates went through biochemical tests for phenotypic identification. Results were confirmed through PCR technique by targeting invA gene. Antimicrobial susceptibility test was conducted by means of disk diffusion method.
Results: The rate of contamination with Salmonella bacteria was 6.57% in all samples. The PCR assay of all isolates showed that 23 isolates (100%) carried the invA gene. No significant association between the frequency of salmonella spp. and types of dairy and their origin was reported (P&gt;0.05). The highest antibiotic resistance rate among the isolates belonged to tetracycline (34.8%) and the highest sensitivity was seen to imipenem, cefepime, and cefotaxime (each 91.3%).
Conclusion: According to our results there has been a rise in multiple drug resistance and contamination rate in traditional dairy products in Yazd province.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4679</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4679/1726</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Anti-invasion activities of heat-killed lactic acid bacteria isolates against Salmonella enterica serovar Typhimurium</title>
    <FirstPage>763</FirstPage>
    <LastPage>772</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Anis Syahirah</FirstName>
        <LastName>Saifor Adzuan</LastName>
        <affiliation locale="en_US">Microbial Metabolite Laboratory, Atta-ur-Rahman Institute for Natural Products Discovery (AuRIns), Universiti Teknologi MARA (UiTM), Puncak Alam, Selangor, Malaysia; School of Biology, Faculty of Applied Sciences, Universiti Teknologi MARA (UiTM), Shah Alam, Selangor, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Sharifah Aminah</FirstName>
        <LastName>Syed Mohamad</LastName>
        <affiliation locale="en_US">Microbial Metabolite Laboratory, Atta-ur-Rahman Institute for Natural Products Discovery (AuRIns), Universiti Teknologi MARA (UiTM), Puncak Alam, Selangor, Malaysia; School of Biology, Faculty of Applied Sciences, Universiti Teknologi MARA (UiTM), Shah Alam, Selangor, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Rashidah</FirstName>
        <LastName>Iberahim</LastName>
        <affiliation locale="en_US">School of Biology, Faculty of Applied Sciences, Universiti Teknologi MARA (UiTM), Kuala Pilah, Negeri Sembilan, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Noor Nadia</FirstName>
        <LastName>Syahira Mohd Kamal</LastName>
        <affiliation locale="en_US">School of Biology, Faculty of Applied Sciences, Universiti Teknologi MARA (UiTM), Shah Alam, Selangor, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Nurliana</FirstName>
        <LastName>Abd Mutalib</LastName>
        <affiliation locale="en_US">Microbial Metabolite Laboratory, Atta-ur-Rahman Institute for Natural Products Discovery (AuRIns), Universiti Teknologi MARA (UiTM), Puncak Alam, Selangor, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Nur Intan</FirstName>
        <LastName>Hasbullah</LastName>
        <affiliation locale="en_US">Microbial Metabolite Laboratory, Atta-ur-Rahman Institute for Natural Products Discovery (AuRIns), Universiti Teknologi MARA (UiTM), Puncak Alam, Selangor, Malaysia; School of Biology, Faculty of Applied Sciences, Universiti Teknologi MARA (UiTM), Kuala Pilah, Negeri Sembilan, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Muneer</FirstName>
        <LastName>Alsaydi</LastName>
        <affiliation locale="en_US">Microbial Metabolite Laboratory, Atta-ur-Rahman Institute for Natural Products Discovery (AuRIns), Universiti Teknologi MARA (UiTM), Puncak Alam, Selangor, Malaysia; Department of Food Science and Technology, Faculty of Agriculture, Ibb University, Ibb, Yemen</affiliation>
      </Author>
      <Author>
        <FirstName>Nor'aishah</FirstName>
        <LastName>Hasan</LastName>
        <affiliation locale="en_US">School of Biology, Faculty of Applied Sciences, Universiti Teknologi MARA (UiTM), Kuala Pilah, Negeri Sembilan, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Low Kheng</FirstName>
        <LastName>Oon</LastName>
        <affiliation locale="en_US">Cell and Synthetic Biology Centre, Malaysia Genome and Vaccine Institute (MGVI), National Institutes of Biotechnology Malaysia (NIBM), Kajang, Selangor, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Olaide</FirstName>
        <LastName>Olawunmi Ajibola</LastName>
        <affiliation locale="en_US">Faculty of Resource Science and Technology, Universiti Malaysia Sarawak (UNIMAS), Kota Samarahan, Sarawak, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Rozila</FirstName>
        <LastName>Alias</LastName>
        <affiliation locale="en_US">Centre for Foundation and General Studies, Universiti Selangor, Shah Alam, Selangor, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Maimunah</FirstName>
        <LastName>Mustakim</LastName>
        <affiliation locale="en_US">Centre for Medical Laboratory Technology Studies, Faculty of Health Sciences, Universiti Teknologi MARA (UiTM), Puncak Alam, Selangor, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Azlin Sham</FirstName>
        <LastName>Rambely</LastName>
        <affiliation locale="en_US">Centre for Medical Laboratory Technology Studies, Faculty of Health Sciences, Universiti Teknologi MARA (UiTM), Puncak Alam, Selangor, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Emida</FirstName>
        <LastName>Mohamed</LastName>
        <affiliation locale="en_US">Centre for Medical Laboratory Technology Studies, Faculty of Health Sciences, Universiti Teknologi MARA (UiTM), Puncak Alam, Selangor, Malaysia</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Pourmand</LastName>
        <affiliation locale="en_US">Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>04</Month>
        <Day>22</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>07</Month>
        <Day>30</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: The most common cause of severe foodborne salmonellosis is S. Typhimurium. Its interaction with intestinal epithelial cells is little known. Lactic acid bacteria (LAB) were recognized as a prominent probiotic gastrointestinal microbiota of humans and animals that confer health-promoting and protective effects. This study aims to determine the anti-invasion and antibacterial effects of heat-killed LAB (HK-LAB) isolates against S. Typhimurium towards human intestinal cells.
Materials and Methods: 12 HK-LAB isolates from 3 sources of origin (stingless bee, plant, and food) were tested to determine the adhesion of HK-LAB to Caco-2 cells, anti-invasion and antibacterial activities against S. Typhimurium, the adhesion and invasion pattern of S. Typhimurium on intestinal epithelial cells (Caco-2) and assessing the effect of LAB on the S. Typhimurium-host cell interaction.
Results: Tairu isolates from food have the highest adhesion rate with 19 &#xB1; 1.32/10 Caco-2 cells followed by HK-LAB R-isolate from plant 17 &#xB1; 0.70/10 Caco-2 cells, which is similar to the control (Lactobacillus casei). In the anti-invasion assay, the two HK-LAB isolates that had the strongest adherence to Caco-2 cells, Tairu-isolate inhibited at 78.1 &#xB1; 3.06% and R-isolate inhibited at 64.76 &#xB1; 9.02% compared to the positive control (63.81 &#xB1; 1.15%), which led to increased suppression of S. Typhimurium accordingly. Tairu and R isolates were tested for their antibacterial ability against S. Typhimurium. Both R and Tairu isolates displayed strong inhibition zones (27 &#xB1; 0.06 mm, 23 &#xB1; 0.06 mm) respectively.
Conclusion: These findings suggest that the anti-invasion activities of HK-LAB R and Tairu may correlate to their bactericidal effects that serve to protect the host from infection.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4746</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4746/1727</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Seroprevalence of Helicobacter pylori in a population of 15 to 35 years old in Mashhad</title>
    <FirstPage>773</FirstPage>
    <LastPage>779</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mahdieh</FirstName>
        <LastName>Khoshakhlagh</LastName>
        <affiliation locale="en_US">Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammadreza</FirstName>
        <LastName>Tarahomi</LastName>
        <affiliation locale="en_US">Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Asgharian</LastName>
        <affiliation locale="en_US">Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Arghavan</FirstName>
        <LastName>Kamali</LastName>
        <affiliation locale="en_US">Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Safoora</FirstName>
        <LastName>Sa'd Abadi</LastName>
        <affiliation locale="en_US">Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Kimia</FirstName>
        <LastName>Jafarpour</LastName>
        <affiliation locale="en_US">Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Samaneh</FirstName>
        <LastName>Abolbashari</LastName>
        <affiliation locale="en_US">Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mojtaba</FirstName>
        <LastName>Meshkat</LastName>
        <affiliation locale="en_US">Department of Community Medicine, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Aida</FirstName>
        <LastName>Gholoobi</LastName>
        <affiliation locale="en_US">Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>08</Month>
        <Day>06</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>10</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Helicobacter pylori (H. pylori) is a bacterium involved in gastrointestinal disorders with a high prevalence in Iran. We have determined the seroprevalence of H. pylori in the young adult population of Mashhad city for the first time.
Materials and Methods: We carried out a cross-sectional study on 933 individuals between the ages of 15 and 35 in Mashhad. The serum level of IgG, IgM, and IgA H. pylori antibodies was determined using enzyme linked immunosorbent assay (ELISA) method.
Results: The average age of the participants including 290 (31.0%) male and 643 (68.9%) female cases was 25.47 &#xB1; 5.76. H. pylori IgG was seropositive in 365 (39.1%) of subjects. Occupation (p=0.002), body mass index (p=0.002), marital status (p&lt;0.0001), and age (p&lt;0.007) were meaningfully related to H. pylori IgG seropositivity. Other factors such as sex, educational attainment, history of chronic diseases, and smoking cigarette had no significant relationship with the presence of H. pylori antibodies.
Conclusion: The seroprevalence of H. pylori IgG antibodies in Mashhad's 15 to 35 years old citizens was determined 39.1%. We suggest further studies with larger sample sizes and different age groups as the target population.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4347</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4347/1728</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Efficacy of traditional herb aqua extract of Teucrium stocksianum and its fractions against HSV-1 virus expression levels of genes (UL46 and US6)</title>
    <FirstPage>780</FirstPage>
    <LastPage>785</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Emad</FirstName>
        <LastName>Asgari</LastName>
        <affiliation locale="en_US">Department of Theriogenology, School of Veterinary Medicine, University of Tehran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zohreh</FirstName>
        <LastName>Sharifi</LastName>
        <affiliation locale="en_US">Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farahnaz</FirstName>
        <LastName>Bineshian</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahsa</FirstName>
        <LastName>Zamanian</LastName>
        <affiliation locale="en_US">Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>04</Month>
        <Day>14</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Recently, the anti-herpetic activities of different plant species have been investigated. This study evaluated the effects of Teucrium stocksianum aqueous extract on the HSV-1 virus-infected Vero cell.
Materials and Methods: The IC50 of the aqueous extract was obtained by the maceration of the plant in boiling water and has been measured with the MTT method, also the q-PCR was used to study viral gene expression reduction.
Results: Results of the MTT test indicated that the highest percentage of metabolic activity was observed in the 75 &#x3BC;g/ml concentration of Teucrium stocksianum&#x2019;s aqueous extracts (IC50=45.5&#x3BC;g/ml). Time intervals of 24 and 48 hours after viral infection revealed that the cell viability is reduced by the viral infection time (MOI=0.1), log 10-3, p &lt;0.001). Furthermore, the plant&#x2019;s aqueous extract concentration almost avoids cell viability reduction. Through Q-PCR results; the reduction of viral proliferation revealed that the low expression of genes UL46 and US6 were significant in the presence of different treatments utilized in the experiment.
Conclusion: T. stocksianum, has an anti-viral property and may be considered as a remedy for anti-HSV-1 agents.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4723</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4723/1729</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitro</title>
    <FirstPage>786</FirstPage>
    <LastPage>791</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Javad</FirstName>
        <LastName>Charostad</LastName>
        <affiliation locale="en_US">Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Tahere</FirstName>
        <LastName>Navidfar</LastName>
        <affiliation locale="en_US">Department of Basic Sciences, Shoushtar Faculty of Medical Sciences, Shushtar University of Medical and Science, Shushtar, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Masoumeh</FirstName>
        <LastName>Kiani</LastName>
        <affiliation locale="en_US">Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Paul</FirstName>
        <LastName>Schinitzler</LastName>
        <affiliation locale="en_US">Department of Infectious Diseases, Virology, University of Heidelberg, Heidelberg, Germany</affiliation>
      </Author>
      <Author>
        <FirstName>Akram</FirstName>
        <LastName>Astani</LastName>
        <affiliation locale="en_US">Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>01</Month>
        <Day>10</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Medicinal plants are the primary treatment for many infectious and non-infectious diseases. In this study, we evaluated the antiviral activity of Ferula assa-feotida against herpes simplex viruses 1 and 2, and compared it with the antiviral drug acyclovir.
Materials and Methods: In our experimental study, Ferula assa-feotida was dissolved in DMSO, then diluted in DMEM medium. Acyclovir was used at a concentration of 100 &#x3BC;M in all procedures. The antiherpetic activity and Antiviral activity of Ferula were evaluated in Vero cells (African green monkey kidney cells) by using the plaque reduction assay.
Results: Inhibitory concentrations of 50% (IC50) of Ferula assa-feotida for HSV-1 and HSV-2 were determined at 0.00025% and 0.00015%, respectively. Ferula was introduced at various stages of viral infection and significantly inhibited HSV-1 and HSV-2 infectivity by &gt; 95.5% and 89%, respectively, when virus was pre-treated before addition to the cells. No HSV-1 or HSV-2 activity was detected in cells treated prior to and following viral infection.
Conclusion: These results indicate that Ferula assa-feotida demonstrates antiherpetic activity in the early phase of viral infection and could be used as potential antiviral agent.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4559</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4559/1730</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Distribution of fungal agents in the respiratory system of patients with underlying lung diseases; molecular identification and antifungal susceptibility profiles</title>
    <FirstPage>792</FirstPage>
    <LastPage>802</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Parviz</FirstName>
        <LastName>Hassanpour</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Jamal</FirstName>
        <LastName>Hashemi</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Food Microbiology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sanam</FirstName>
        <LastName>Nami</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Roshanak</FirstName>
        <LastName>Daie Ghazvini</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Behrouz</FirstName>
        <LastName>Naghili Hokmabadi</LastName>
        <affiliation locale="en_US">Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Rahimi Foroushani</LastName>
        <affiliation locale="en_US">Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Kazem</FirstName>
        <LastName>Ahmadikia</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Ramezanalipour</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Saeid</FirstName>
        <LastName>Firouzi Abriz</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>05</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Airway fungal infection is a severe clinical problem, especially in patients with compromised immune functions. Here, we examined the distribution and antifungal susceptibility profiles of fungal agents isolated from respiratory tract of symptomatic patients hospitalized in pulmonary units.
Materials and Methods: This descriptive cross-sectional study took place from 2023 to 2024, involving 360 patients. Bronchoalveolar lavage (BAL) or sputum specimens were collected and analyzed using mycological and molecular methods for this study. Antifungal susceptibility testing (AFST) was carried out using the broth micro dilution method.
Results: Of a total of 360 respiratory specimens, 114 (31.6%) were positive. The male-to-female ratio was 63:51 (1.3%). Candida albicans and Aspergillus flavus were the most common yeast and mold species. Chronic obstructive pulmonary disease (COPD) had the highest rate of colonization with fungal agents (47/114, 41%). The isolates associated with COPD in this study included Aspergillus species (4/12, 3.5%), Candida species (41/96, 36%), and other fungal species (2/6, 1.5%). Coughing (87%) was the predominant symptom, and malignancy (52%) was the predominant comorbidity factor. The result of AFST for antifungal agents showed that 9 (22.5%) Candida isolates were resistant, and the highest rate of resistance was related to voriconazole agent (5/9, 55.5%). Resistance to antifungal agents was not observed among Aspergillus isolates.
Conclusion: This study showed a significant relationship between the frequency of Aspergillus and Candida species in patients with underlying lung diseases. In addition, voriconazole was more effective than itraconazole, especially against Aspergillus flavus.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/4825</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/4825/1731</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>16</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Exploring oral candidiasis among cancer patients undergoing chemotherapy in eastern Iran</title>
    <FirstPage>803</FirstPage>
    <LastPage>811</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Abdol Sattar</FirstName>
        <LastName>Pagheh</LastName>
        <affiliation locale="en_US">Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Kardan</LastName>
        <affiliation locale="en_US">Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Aynaz</FirstName>
        <LastName>Ghojoghi</LastName>
        <affiliation locale="en_US">Department of Medical Mycology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ahmad Reza</FirstName>
        <LastName>Sebzari</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Erfaninejad</LastName>
        <affiliation locale="en_US">Department of Basic Medical Sciences, Shoushtar Faculty of Medical Sciences, Shoushtar, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Parvin</FirstName>
        <LastName>Askari</LastName>
        <affiliation locale="en_US">Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Reza</FirstName>
        <LastName>Aghili</LastName>
        <affiliation locale="en_US">Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Eisa</FirstName>
        <LastName>Nazar</LastName>
        <affiliation locale="en_US">Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Masood</FirstName>
        <LastName>Ziaee</LastName>
        <affiliation locale="en_US">Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>07</Month>
        <Day>17</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>06</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objecti Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Parinaz</FirstName>
        <LastName>Ghadam</LastName>
        <affiliation locale="en_US">Department of Biotechnology, Faculty of Biological Sciences, Alzahra University, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>06</Month>
        <Day>18</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>02</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: The interaction between nanoparticles (NPs) and viruses is attracting interest because of the antiviral potential of NPs. This study aims to investigate the antiviral potential of NPs against Herpes simplex virus types 1 (HSV-1).
Materials and Methods: Molecular docking studies were conducted by Molegro virtual docker software. An extract of Juglans regia green husk was utilized to biosynthesize copper-oxide nanoparticles (CuNPs). The cytotoxicity of NPs was evaluated by MTT assay. Different treatment assays were conducted. Another assay was designed to employ the concentration of 300 &#x3BC;g/ml of CuNPs, which is the highest concentration that did not precipitate. Finally, chemically synthesized Iron oxide nanoparticles (FeNPs) were utilized to adsorb CuNPs. The antiviral effect of FeNPs was investigated, separately.
Results: Docking results confirmed that NPs could interact with the HSV-1 glycoproteins and prevent viral entry. MTT assay results illustrated that the minimum non-toxic concentration (MNTD) of CuNPs is 100 &#x3BC;g/ml which did not exhibit antiviral properties. Employing a noncytotoxic concentration of FeNPs (300 mg/ml) in combination with cytotoxic concentration of CuNPs (300 &#x3BC;g /ml), eliminated the cytotoxicity effects of CuNPs. Exposure of the virus with the combination of CuNPs and FeNPs resulted in 4.5 log10 TCID50 reductions in HSV-1. While treating HSV-1 with only FeNPs reduced the titer of virus by 3.25 log10 TCID50.
Conclusion: The results highlight that combination of CuNPs and FeNPs have antiviral activity against HSV-1. Moreover, FeNPs demonstrated antiviral properties against HSV-1 separately.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/3777</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/3777/1551</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>15</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Prevalence of herpes simplex viruses types 1 and 2 infections among suspected children of encephalitis in Kermanshah, Iran</title>
    <FirstPage>149</FirstPage>
    <LastPage>154</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Kamal</FirstName>
        <LastName>Fakhredini</LastName>
        <affiliation locale="en_US">Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hoorieh</FirstName>
        <LastName>Soleimanjahi</LastName>
        <affiliation locale="en_US">Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Taravat</FirstName>
        <LastName>Bamdad</LastName>
        <affiliation locale="en_US">Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>11</Month>
        <Day>07</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>12</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Various infectious and non-infectious factors can cause encephalitis in the central nervous system (CNS), the most important of which are viruses. Herpes viruses are one of the most important causes of encephalitis worldwide. PCR detected the virus on the cerebrospinal fluid (CSF) sample. The aim of this study was to set up an in-house PCR to identify herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) and determine the prevalence of these viruses in suspected children of encephalitis.
Materials and Methods: This cross-sectional study was conducted on 160 suspected children with encephalitis cases referred to Dr. Kermanshahi Children Hospital, Kermanshah, Iran, from April to March 2021. CSF samples were extracted using a viral extraction kit, and a PCR was performed. The level of glucose and total protein of the samples was measured.
Results: The total prevalence of HSV was 16.25%. 17 samples were positive for HSV-1 (10.6%), and 9 samples for HSV-2 (5.6%). There was a significant correlation between glucose, total protein, and HSV PCR positive, but no significant correlation between age and HSV PCR positive results.
Conclusion: Rapid diagnosis of a virus may reduce the hospitalization rate and the use of unnecessary therapies and crease mortality, morbidity, and disability in children. Results in this study show that the distribution of HSV types in children with encephalitis predominantly was type 1 compared with type 2.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/3964</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/3964/1552</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>15</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Phylogenetic characterization of rhinovirus and adenovirus in hospitalized children aged &#x2264; 18 years with severe acute respiratory infection in Iran</title>
    <FirstPage>155</FirstPage>
    <LastPage>162</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Simin</FirstName>
        <LastName>Abbasi</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of  Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nazanin Zahra</FirstName>
        <LastName>Shafiei-Jandaghi</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of  Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Azadeh</FirstName>
        <LastName>Shadab</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of  Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Abbas</FirstName>
        <LastName>Hassani</LastName>
        <affiliation locale="en_US">Department of Pediatric Intensive Care Unit, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Rahimi Foroushani</LastName>
        <affiliation locale="en_US">Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nazanin</FirstName>
        <LastName>Hosseinkhan</LastName>
        <affiliation locale="en_US">Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fahimeh</FirstName>
        <LastName>Aghamir</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of  Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Talat</FirstName>
        <LastName>Mokhtari-Azad</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of  Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Jila</FirstName>
        <LastName>Yavarian</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, Tehran University of  Medical Sciences, Tehran, Iran AND Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>07</Month>
        <Day>13</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>12</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Human rhinoviruses (HRVs) and human adenoviruses (HAdVs) are among the most prevalent viruses in hospitalized patients with severe acute respiratory infection (SARI). This study aimed to evaluate the molecular characterization of HRV and HAdV in hospitalized patients with SARI, who aged &#x2264; 18 years in Tehran, Iran.
Materials and Methods: To detect these two viruses, a conventional nested RT-PCR (Reverse transcription-polymerase chain reaction) assay was performed on 264 throat swabs collected from December 2018 to March 2019. The epidemiological data were analyzed and phylogenetic trees were constructed.
Results: Of 264 cases with SARI, 36 (13.6%) and 28 (10.6%) were positive for HAdV and HRV respectively. Of 21 HRV sequenced samples, HRV-A (42.9%), HRV-B (9.5%) and HRV-C (47.6%) and of 36 HAdV sequenced samples, HAdV-C6 (38.9%), HAdV-B7 (22.2%), HAdV-B3 (11.1%), HAdV-B16 (5.6%), HAdV-C5 (13.9%), HAdV-C57 (5.6%), HAdV-E4 (2.8%); were detected in children with SARI. Some viral genotypes appeared to cause more severe disease, which may lead to hospitalization.
Conclusion: Large-scale studies are recommended to investigate the epidemiology and molecular characterizations through surveillance networks to provide useful information on etiology, seasonality, and demographic associations in patients with SARI.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/3813</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/3813/1553</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>15</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluation of virulence factors and azole resistance mechanisms of Candida tropicalis isolates from head and neck cancer patients with OPC</title>
    <FirstPage>163</FirstPage>
    <LastPage>173</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Jahanshiri</LastName>
        <affiliation locale="en_US">Department of Mycology, Pasteur Institute of Iran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Soheila</FirstName>
        <LastName>Manifar</LastName>
        <affiliation locale="en_US">Department of Oral Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farahnaz</FirstName>
        <LastName>Hatami</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Biology, Facult